Suven Life Sciences Ltd.

NSE: SUVEN | BSE: 530239 | ISIN: INE495B01038 | Industry: Healthcare Services
|

128.72
-2.05%

Suven LifeSciences has seen a strong Q3 - albeit tempered from the Q2 this year - that will help the company end FY17 on a high note. The company declared a Q3 jump in net profit jump of 34.3% compared to the same quarter last year, with operating margins year on year helped by lower expenses and finance costs.

QoQ performance for the company saw net profits fall 8.6%, although for the overall nine month period Suven's incomes are up 9.98% and profits up 32.77% compared to the previous year. The company has secured 5 product patents in neurodegenerative treatments over the financial year, including Alzheimer's treatments. 

Suven Life Sciences Ltd. is trading below its 150 day SMA of 130.6
More from Suven Life Sciences Ltd.
Recommended